These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2720698)
1. A metric for the evaluation of change in clinical trials. Brouwers P; Mohr E Clin Neuropharmacol; 1989 Apr; 12(2):129-33. PubMed ID: 2720698 [No Abstract] [Full Text] [Related]
2. The two-period cross-over clinical trial. Hills M; Armitage P Br J Clin Pharmacol; 1979 Jul; 8(1):7-20. PubMed ID: 552299 [No Abstract] [Full Text] [Related]
3. The effect of diagnostic criteria on the efficiency of experimental clinical trials. Howat AP; Holloway PJ J Dent Res; 1977 Oct; 56 Spec No():C116-22. PubMed ID: 344367 [No Abstract] [Full Text] [Related]
4. A model for incorporating historical controls into a meta-analysis. Begg CB; Pilote L Biometrics; 1991 Sep; 47(3):899-906. PubMed ID: 1742445 [TBL] [Abstract][Full Text] [Related]
5. The evaluation of clinical trials. Jackson RR Postgrad Med J; 1985 Feb; 61(712):133-9. PubMed ID: 3983040 [No Abstract] [Full Text] [Related]
6. [Case number estimation and in-between evaluation]. Neiss A; Köpcke W; Uberla KK Internist (Berl); 1982 Apr; 23(4):195-200. PubMed ID: 7045021 [No Abstract] [Full Text] [Related]
7. Eligibility and extrapolation in cancer clinical trials. Begg CB; Engstrom PF J Clin Oncol; 1987 Jun; 5(6):962-8. PubMed ID: 3585451 [No Abstract] [Full Text] [Related]
8. Economic evaluations alongside equivalence and noninferiority trials. Gandjour A Value Health; 2009 Jun; 12(4):628; author reply 629. PubMed ID: 19900261 [No Abstract] [Full Text] [Related]
10. [Meta-analysis of the effectiveness of therapeutic methods]. Bogdanik T Pol Tyg Lek; 1992 Mar 16-30; 47(11-13):285-8. PubMed ID: 1437732 [No Abstract] [Full Text] [Related]
11. Assessing the value of diagnostic tests: a framework for designing and evaluating trials. Ferrante di Ruffano L; Hyde CJ; McCaffery KJ; Bossuyt PM; Deeks JJ BMJ; 2012 Feb; 344():e686. PubMed ID: 22354600 [No Abstract] [Full Text] [Related]
12. Clinical trials: the gold standard for evaluation of therapy. Meinert CL Ophthalmology; 1996 Jun; 103(6):869-70. PubMed ID: 8643240 [No Abstract] [Full Text] [Related]
13. An evaluation of clinical trial designs that randomize composite units rather than individual patients. Simon R Experientia Suppl; 1982; 41():318-26. PubMed ID: 6958521 [No Abstract] [Full Text] [Related]
14. The role of observational studies in the evaluation of therapy. Feinstein A Stat Med; 1984; 3(4):341-5. PubMed ID: 6528134 [No Abstract] [Full Text] [Related]
15. We have a problem: why have ALS trials been negative? Swash M Amyotroph Lateral Scler; 2007 Oct; 8(5):259. PubMed ID: 17917847 [No Abstract] [Full Text] [Related]
16. Postmarketing studies of drug efficacy: when must they be randomized? Strom BL; Miettinen OS; Melmon KL Clin Pharmacol Ther; 1983 Jul; 34(1):1-7. PubMed ID: 6861430 [No Abstract] [Full Text] [Related]
17. Considerations in the analysis of site-specific dichotomous responses. Gunsolley JC; Best AM J Periodontal Res; 1992 Jul; 27(4 Pt 2):352-5. PubMed ID: 1507024 [No Abstract] [Full Text] [Related]
18. What price Kaplan-Meier? Miller RG Biometrics; 1983 Dec; 39(4):1077-81. PubMed ID: 6671119 [TBL] [Abstract][Full Text] [Related]
20. A method for the evaluation of dose-toxicity relationships in clinical trials. Mather FJ; Simon RM; Clark GM; Von Hoff DD Stat Med; 1990 Sep; 9(9):1117-8. PubMed ID: 2244083 [No Abstract] [Full Text] [Related] [Next] [New Search]